Skip navigation

Evaluation of clay functionalized wafers and films for nicotine replacement therapy via buccal mucosa

Evaluation of clay functionalized wafers and films for nicotine replacement therapy via buccal mucosa

Boateng, Joshua ORCID: 0000-0002-6310-729X and Okeke, Obinna (2019) Evaluation of clay functionalized wafers and films for nicotine replacement therapy via buccal mucosa. Pharmaceutics, 11 (3):104. ISSN 1999-4923 (Online) (doi:https://doi.org/10.3390/pharmaceutics11030104)

[img]
Preview
PDF (Publisher's PDF - Open Access)
23273 BOATENG_Evaluation_of_Clay-Functionalized_Wafers_and_Films_(OA)_2019.pdf - Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview

Abstract

The functional physicochemical properties of nicotine (NIC)-loaded composite freeze-dried wafers and solvent-evaporated films comprising hydroxypropylmethylcellulose (HPMC) and sodium alginate (SA), stabilized with magnesium aluminium silicate (MAS), have been reported. The formulations were characterized for swelling capacity, mucoadhesion, in vitro drug dissolution properties in simulated saliva (SS) and PBS at pH 6.8, and ex vivo and in vitro permeation using pig buccal mucosa membrane and EpiOralTM buccal tissue culture, respectively; finally, the cell viability of the EpiOralTM tissues after contact with the NIC-loaded formulations was investigated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and the functional characteristics compared with those of commercially available NIC strips. Swelling and NIC release from the HPMC–SA wafers were more prolonged (30 min) compared to the commercially available NIC strips which disintegrated rapidly and released the drug within 5 min. Generally, swelling, mucoadhesion, and drug release was faster in PBS than in SS, and the presence of MAS was essential for maintaining a high dose recovery compared to non-MAS formulations and commercial NIC strips, which showed lower percentage of NIC content, possibly due to evaporation during analysis. Permeation studies showed that the NIC released was able to cross both porcine buccal membrane and the EpiOralTM buccal tissue, with the latter showing higher permeation flux for all the formulations tested. All the NIC-loaded, MAS-stabilized formulations showed high tissue viability, with values above 80%, showing their great potential for use as buccal delivery platforms for NIC replacement therapy to aid smoking cessation.

Item Type: Article
Additional Information: © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Uncontrolled Keywords: buccal delivery; cell viability; films; HPMC; nicotine; permeation; sodium alginate; wafers
Subjects: R Medicine > RM Therapeutics. Pharmacology
Faculty / Department / Research Group: Faculty of Engineering & Science
Faculty of Engineering & Science > Department of Pharmaceutical, Chemical & Environmental Sciences
Last Modified: 06 Apr 2019 23:27
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: None
Selected for GREAT 2019: None
URI: http://gala.gre.ac.uk/id/eprint/23273

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics